Jie-Hyun Kim Selected Research

Gastroesophageal Reflux (GERD)

1/2023	A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease.
12/2022	Triglyceride-glucose index is associated with gastroesophageal reflux disease and erosive reflux disease: a health checkup cohort study.
7/2017	Clinical Characteristics of Patients with Untreated Achalasia.
9/2014	[Current issues on gastroesophageal reflux disease].
3/2014	The impact of esophageal reflux-induced symptoms on quality of life after gastrectomy in patients with gastric cancer.
1/2014	A Case of Postfundoplication Dysphagia without Symptomatic Improvement after Endoscopic Dilatation.
10/2013	Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie-Hyun Kim Research Topics

Disease

16	Stomach Neoplasms (Stomach Cancer) 09/2023 - 01/2006
15	Neoplasms (Cancer) 01/2023 - 01/2006
7	Gastroesophageal Reflux (GERD) 01/2023 - 10/2013
5	Carcinogenesis 03/2022 - 01/2019
5	Infections 01/2022 - 12/2006
4	Ulcer 01/2021 - 12/2008
4	Esophageal Achalasia (Megaesophagus) 03/2018 - 07/2013
3	Lymphatic Metastasis 04/2021 - 01/2020
3	Pathologic Constriction (Stenosis) 02/2018 - 11/2011
2	Eosinophilic Esophagitis 04/2024 - 01/2013
2	Gastritis 06/2023 - 09/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2022
2	Hemorrhage 03/2022 - 01/2018
2	Esophageal Squamous Cell Carcinoma 03/2021 - 01/2014
2	Gastric Outlet Obstruction 05/2020 - 01/2013
2	Heartburn (Pyrosis) 11/2019 - 07/2017
2	Peptic Ulcer (Peptic Ulcers) 09/2019 - 01/2018
2	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 02/2018
2	Peritoneal Neoplasms 12/2018 - 06/2018
2	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 01/2017
2	Gastrointestinal Hemorrhage (Hematochezia) 05/2018 - 04/2011
2	Deglutition Disorders (Dysphagia) 01/2014 - 04/2013
1	Hypotension (Low Blood Pressure) 04/2023
1	Glaucoma 04/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022
1	Esophagitis 11/2022
1	Atrophic Gastritis 01/2022
1	Rheumatoid Arthritis 01/2022
1	Ulcerative Colitis 01/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Stomach Diseases 01/2022
1	Ankylosing Spondylitis 01/2022
1	Metaplasia 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Precancerous Conditions 01/2022
1	Ileus 10/2021
1	Dysbiosis 08/2020
1	Peptic Esophagitis (Reflux Esophagitis) 11/2019
1	Wounds and Injuries (Trauma) 09/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Sarcopenia 01/2019
1	Carcinoma (Carcinomatosis) 12/2018

Drug/Important Bio-Agent (IBA)

7	Proton Pump InhibitorsIBA 01/2021 - 04/2013
6	Triglycerides (Triacylglycerol)IBA 12/2022 - 01/2017
5	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 11/2021
3	CateninsIBA 09/2023 - 05/2012
3	Esomeprazole (Nexium)FDA Link 06/2023 - 11/2022
3	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 03/2018
3	WD repeat containing planar cell polarity effectorIBA 05/2022 - 02/2010
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2019 - 01/2006
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2019 - 01/2006
2	Epidermal Growth Factor (EGF)IBA 09/2023 - 01/2019
2	Famotidine (Pepcid)FDA LinkGeneric 06/2023 - 01/2021
2	Immunomodulating AgentsIBA 01/2023 - 01/2022
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2023 - 11/2019
2	ORALIT (ORS)IBA 12/2022 - 01/2022
2	AcidsIBA 01/2022 - 12/2015
2	Butyric Acid (Butanoic Acid)IBA 05/2012 - 02/2010
2	Lactulose (Duphalac)FDA LinkGeneric 07/2011 - 10/2010
1	Immunoglobulins (Immunoglobulin)IBA 04/2024
1	Trastuzumab (Herceptin)FDA Link 09/2023
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 04/2023
1	Angiotensin IIIBA 04/2023
1	Collagen Type I (Type I Collagen)IBA 04/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2023
1	fexuprazanIBA 11/2022
1	ParaffinIBA 05/2022
1	Formaldehyde (Formol)FDA Link 05/2022
1	RNA (Ribonucleic Acid)IBA 05/2022
1	AnticoagulantsIBA 03/2022
1	tegoprazanIBA 01/2022
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2022
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	PotassiumIBA 01/2022
1	C-Reactive ProteinIBA 10/2021
1	Ranitidine (Zantac)FDA LinkGeneric 01/2021
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2021
1	polaprezinc (Z 103)IBA 01/2021
1	rebamipideIBA 01/2021
1	Pantoprazole (Protonix)FDA LinkGeneric 01/2021
1	SmectiteIBA 08/2020
1	Gentamicins (Gentamicin)FDA LinkGeneric 08/2020
1	AlginatesIBA 11/2019
1	Protective AgentsIBA 09/2019
1	irsogladineIBA 09/2019

Therapy/Procedure

8	Therapeutics 03/2022 - 12/2006
5	Stents 05/2020 - 01/2013
4	Lymph Node Excision (Lymph Node Dissection) 04/2021 - 03/2012
4	Self Expandable Metallic Stents 05/2020 - 01/2013
3	Drug Therapy (Chemotherapy) 05/2022 - 06/2007
2	Gastrectomy 10/2021 - 03/2014
2	Chemoradiotherapy 03/2021 - 01/2014
2	Radiotherapy 01/2019 - 02/2018
2	Aftercare (After-Treatment) 10/2013 - 04/2013
1	Length of Stay 10/2021